Supplementary Figure from A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)
Feng Wang(Sun Yat-sen University), Rui‐Hua Xu(Sun Yat-sen University), Ying Guo(Sun Yat-sen University), Zong-Jiong Mai(Sun Yat-sen University), Si‐Mei Shi(Sun Yat-sen University), Fuxiang Zhou(Wuhan University), Zhigang Ma(Gansu Provincial Hospital), Yichen Yao(Sun Yat-sen University), Xiao-Hua Hu(First Affiliated Hospital of GuangXi Medical University), Qing-Feng Zou(Guangzhou Medical University Cancer Hospital), Xiangyuan Wu(Zhejiang University), Zengqing Guo(Fujian Provincial Cancer Hospital), Ying Yuan(Zhejiang Cancer Hospital), Ying Jin(Harbin Medical University), Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhixiang Zhuang(Soochow University), Wei Wang(First People's Hospital of Foshan), Yanqiao Zhang(Harbin Medical University), Jian Xiao(Sun Yat-sen University), Ming-Ming He(Sun Yat-sen University), Yan Zhang(Harbin Medical University), Shuang-Zhen Chen(Sun Yat-sen University), Yuhong Li(Southwest Jiaotong University), Zhi‐Qiang Wang(Nanjing University of Chinese Medicine), Feng‐Hua Wang(Sun Yat-sen University), Hui Luo(Sun Yat-sen University), Hong Qiu(Johnson & Johnson (United States)), Dong‐Sheng Zhang(Sun Yat-sen University), Xianglin Yuan(Tongji Hospital), Weijia Fang(Zhejiang Cancer Hospital)
Cited by 0
Related Papers
Circular RNA: metabolism, functions and interactions with proteins
|Molecular Cancer|2020|1.6k
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
|Molecular Cancer|2019|868